Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vermersch

Showing results (211-220 of 219) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 219 results.
Revue Neurologique|October 22, 2013
[Cavitary lesions in multiple sclerosis: multicenter study on twenty patients]A Corlobé, D Renard, C Goizet, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 21, 2014
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteriaS Schippling, L J Balk, F Costello, et al.
Clinical Immunology (Orlando, Fla.)|December 31, 2010
Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assayI De Vidi, G Boursier, N Delouche, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 18, 2011
High-risk syndrome for neuromyelitis optica: a descriptive and comparative studyN Collongues, R Marignier, H Zéphir, et al.
Revue Neurologique|April 22, 2014
[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects]C Lionnet, C Carra, X Ayrignac, et al.
Experimental Neurology|January 8, 2008
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeatsC M Dhaenens, S Schraen-Maschke, H Tran, et al.
Journal of Neurology|July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patientsG Balloy, J Pelletier, L Suchet, et al.
European Journal of Neurology|July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohortO Outteryck, J C Ongagna, B Brochet, et al.
Neurology|March 3, 2010
Neuromyelitis optica in France: a multicenter study of 125 patientsN Collongues, R Marignier, H Zéphir, et al.
Pageof 22

Showing results (211-220 of 219) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 219 results.
Revue Neurologique|October 22, 2013
[Cavitary lesions in multiple sclerosis: multicenter study on twenty patients]A Corlobé, D Renard, C Goizet, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 21, 2014
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteriaS Schippling, L J Balk, F Costello, et al.
Clinical Immunology (Orlando, Fla.)|December 31, 2010
Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assayI De Vidi, G Boursier, N Delouche, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 18, 2011
High-risk syndrome for neuromyelitis optica: a descriptive and comparative studyN Collongues, R Marignier, H Zéphir, et al.
Revue Neurologique|April 22, 2014
[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects]C Lionnet, C Carra, X Ayrignac, et al.
Experimental Neurology|January 8, 2008
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeatsC M Dhaenens, S Schraen-Maschke, H Tran, et al.
Journal of Neurology|July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patientsG Balloy, J Pelletier, L Suchet, et al.
European Journal of Neurology|July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohortO Outteryck, J C Ongagna, B Brochet, et al.
Neurology|March 3, 2010
Neuromyelitis optica in France: a multicenter study of 125 patientsN Collongues, R Marignier, H Zéphir, et al.
Pageof 22